PMID: 6538102Jan 1, 1984Paper

Urinary androgen and 17-hydroxylated corticosteroid metabolites and their relation to recurrence rates in early breast cancer

Breast Cancer Research and Treatment
B S ThomasR R Millis

Abstract

The amounts of urinary androsterone and etiocholanolone are highly correlated with recurrence rates in patients with early breast cancer after treatment by mastectomy. A more efficient means of predicting the clinical course of the disease is obtained by using a ratio of these compounds to the amounts of individual 17-hydroxycorticosteroids in the urine. For instance, the ratio of androsterone to alpha-cortolone is particularly effective in identifying women with a high rate of recurrence, and this is largely independent of pathological stage and tumor grade.

References

Jul 1, 1977·Journal of the National Cancer Institute·M KodamaM Yoshida
Aug 15, 1977·Clinica Chimica Acta; International Journal of Clinical Chemistry·V Fantl, C H Gray
May 1, 1968·The Journal of Clinical Endocrinology and Metabolism·S KumaokaO Takatani
May 1, 1982·European Journal of Cancer & Clinical Oncology·B S ThomasR R Millis
Mar 1, 1982·British Journal of Cancer·J L HaybittleK Griffiths

❮ Previous
Next ❯

Citations

Jan 1, 1989·Acta Oncologica·R D Bulbrook, B S Thomas
Jun 1, 1993·Critical Reviews in Oncology/hematology·M KodamaM Kodama
Jan 1, 1988·Annals of the New York Academy of Sciences·R D BulbrookD Y Wang
Mar 6, 1999·Breast Cancer Research and Treatment·D Amadori, R Silvestrini
Oct 2, 2020·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lauren C HoughtonMary Beth Terry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.